Evidence map›Paper›PMID 39965789›Full record

ArticleJournal of the Chinese Medical Association : JCMA2025

Comparison of machine learning algorithms for automatic prediction of Alzheimer disease.

Emrah Aslan, Yildirim Özüpak

Abstract readComparative Study
In one paragraph

Article in Journal of the Chinese Medical Association : JCMA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emrah AslanFaculty of Engineering and Architecture, Mardin Artuklu University, Mardin, Turkey.
Yildirim ÖzüpakDepartment of Electricity and Energy, Silvan Vocational School, Dicle University, Diyarbakir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlzheimer disease is a progressive neurological disorder marked by irreversible memory loss and cognitive decline. Traditional diagnostic tools, such as intracranial volume assessments, electroencephalography (EEG) signals, and brain magnetic resonance imaging (MRI), have shown utility in detecting the disease. However, artificial intelligence (AI) offers promise for automating this process, potentially enhancing diagnostic accuracy and accessibility.

methodsIn this study, various machine learning models were used to detect Alzheimer disease, including K-nearest neighbor regression, support vector machines (SVM), AdaBoost regression, and logistic regression. A neural network was constructed and validated using data from 150 participants in the University of Washington's Alzheimer's Disease Research Center (Open Access Imaging Studies Series [OASIS] dataset). Cross-validation was also performed on the Alzheimer Disease Neuroimaging Initiative (ADNI) dataset to assess the robustness of the models.

resultsAmong the models tested, K-nearest neighbor regression achieved the highest accuracy, reaching 97.33%. The cross-validation on the ADNI dataset further confirmed the effectiveness of the models, demonstrating satisfactory results in screening and diagnosing Alzheimer disease in a community-based sample.

conclusionThe findings indicate that AI-based models, particularly K-nearest neighbor regression, provide promising accuracy for the early detection of Alzheimer disease. This approach has potential for further development into practical diagnostic tools that could be applied in clinical and community settings.

Indexed as

AlgorithmsAlzheimer DiseaseMachine LearningAgedFemaleHumansMaleSupport Vector Machine

Identifiers

PMID39965789
PMCPMC12718816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.